MX9700617A - Albumina humana terapeutica con baja capacidad para la fijacion de aluminio. - Google Patents

Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.

Info

Publication number
MX9700617A
MX9700617A MX9700617A MX9700617A MX9700617A MX 9700617 A MX9700617 A MX 9700617A MX 9700617 A MX9700617 A MX 9700617A MX 9700617 A MX9700617 A MX 9700617A MX 9700617 A MX9700617 A MX 9700617A
Authority
MX
Mexico
Prior art keywords
therapeutical
human albumin
albumin
low capacity
aluminum
Prior art date
Application number
MX9700617A
Other languages
English (en)
Other versions
MXPA97000617A (es
Inventor
Pere Ristol Debart
David Camarero Torrecillas
Original Assignee
Grifols Grupo Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8293596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9700617(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Grupo Sa filed Critical Grifols Grupo Sa
Publication of MX9700617A publication Critical patent/MX9700617A/es
Publication of MXPA97000617A publication Critical patent/MXPA97000617A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Albumina humana terapéutica con baja capacidad para la fijacion de aluminio. Se da a conocer una albumina humana terapéutica con muy baja capacidad de absorcion de aluminio, durante el tiempo de almacenamiento en envase de vidrio, en la que la composicion final de la solucion de albumina ajustada de estabilizantes e isotonía a la concentracion del 5,20 o 25% de proteína en medio acuoso, preferentemente, o a cualquier otra concentracion terapéutica aceptable por vía intravenosa, presenta un contenido de citrato en la composicion final de albumina igual o inferior a 0,5 mM (milimolar) y, preferentemente, inferior a 0,037 mM (milimolar).
MXPA/A/1997/000617A 1996-01-30 1997-01-23 Albumina humana terapeutica con baja capacidadpara la fijacion de aluminio MXPA97000617A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES9600200 1996-01-30
ES09600200A ES2103236B1 (es) 1996-01-30 1996-01-30 Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.

Publications (2)

Publication Number Publication Date
MX9700617A true MX9700617A (es) 1997-07-31
MXPA97000617A MXPA97000617A (es) 1997-12-01

Family

ID=

Also Published As

Publication number Publication date
DE69632771T2 (de) 2005-07-07
ES2103236B1 (es) 1998-04-16
JPH09221431A (ja) 1997-08-26
PT787498E (pt) 2004-10-29
DE787498T1 (de) 1999-05-20
ES2220967T3 (es) 2004-12-16
HUP9603601A3 (en) 1998-01-28
ATE269717T1 (de) 2004-07-15
DE69632771D1 (de) 2004-07-29
SK3597A3 (en) 1997-08-06
EP0787498A3 (en) 1998-10-21
AR005374A1 (es) 1999-04-28
EP1413312A3 (en) 2004-09-01
UY24448A1 (es) 1997-02-18
EP1413312A2 (en) 2004-04-28
ES2220256T1 (es) 2004-12-16
HUP9603601A2 (en) 1997-08-28
ES2103236A1 (es) 1997-09-01
SK284297B6 (sk) 2005-01-03
JP3054371B2 (ja) 2000-06-19
US5846930A (en) 1998-12-08
EP0787498B1 (en) 2004-06-23
DK0787498T3 (da) 2004-10-11
CZ289782B6 (cs) 2002-04-17
EP0787498A2 (en) 1997-08-06
HU9603601D0 (en) 1997-02-28
CZ697A3 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
CA2187274A1 (en) Treatment of Partial Growth Hormone Insensitivity Syndrome
TW427905B (en) Aqueous pharmaceutical composition of nerve growth factor
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
CA2343123A1 (en) Active substance concentrate with formoterol, suitable for storage
PL312204A1 (en) Preparation for intrarhinal administration of desmopressin
EP0410207A3 (en) Stabilization of highly purified proteins
EP0347864A3 (en) Anti-atherogenic agents
CA2135614A1 (en) Use of urodilatin in pulmonary and bronchial diseases
ES2103236A1 (es) Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
CA2060560A1 (en) Method for insuring adequate intracellular glutathione in tissue
AU1615992A (en) Use of protein c or activated protein c
CA2127107A1 (en) Methods and compositions for reducing blood loss
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
EP0428879A3 (en) Anhydrous crystal of 4-carbamoyl-1-beta-d-ribofuranosyl imidazolium-5-oleate
GB2236528B (en) Aroyl-ureas
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
SE9402119D0 (sv) Solution
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
Turkel et al. Lithium treatment of a bipolar patient with cystic fibrosis.
Senczuk et al. Toxicodynamic propertes of toluidines. Part II. Blood absorption of toluidines.
许以平 et al. RELATIONSHIP BETWEEN IgD AND ASTHMA
Witkowski et al. Summer dermatoses, Part 1: Acute and chronic effects of the sun.
Aiello et al. Evaluation of efficacy, tolerableness and safety of Enalapril(in single daily dose in patients with mild essential hypertension).
RU99115515A (ru) Средство для коррекции кроветворения и профилактики диспепсии новорожденных телят